Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Everest OrganicsBOM:524790 +2.47%47 Days Inventory is 149.06 as of Mar. 2026, which is 82% above its 10-year median of 81.95. GuruFocus rates BOM:524790 with a GF Score™ of 47/100 and a GF Value™ of ₹129.33 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 922 Drug Manufacturers companies, Everest Organics ranks better than 66.59% on this metric.
The historical rank and industry rank for Everest Organics's Days Inventory or its related term are showing as below:
BOM:524790'
s Days Inventory Range Over the Past 10 Years
Min: 48.17 Med: 81.95 Max: 164.85
Current: 126.11
During the past 13 years, Everest Organics's highest Days Inventory was 164.85. The lowest was 48.17. And the median was 81.95.
BOM:524790's Days Inventory is ranked better than 66.59% of 922
companies
in the Drug Manufacturers industry
Industry Median: 165.005
vs BOM:524790: 126.11
Everest Organics's Days Inventory
declined
from Mar. 2025 (165.88) to Mar. 2026 (149.06).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Everest Organics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.61.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Everest Organics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.92.
Everest Organics (BOM:524790) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Everest Organics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Everest Organics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Everest Organics Days Inventory Related Terms
Everest Organics Days Inventory Historical Data
* Premium members only.
The historical data trend for Everest Organics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Everest Organics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Everest Organics Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Everest Organics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Everest Organics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Everest Organics (BOM:524790) has a Days Inventory of 149.06 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Everest Organics and its competitors. This is 82% above median its historical median of 81.95. Over the past decade, Everest Organics' Days Inventory has ranged from 48.17 to 164.85. According to the industry distribution chart, Everest Organics ranks #308 out of 922 companies in the Drug Manufacturers industry, placing it in the top 33.4%.
Is Everest Organics' Days Inventory too high?
Everest Organics' current Days Inventory of 149.06 is 82% above median its 10-year median of 81.95. Over the past 10 years, this metric has ranged from a low of 48.17 to a high of 164.85. The Drug Manufacturers industry median Days Inventory is 165.01. Everest Organics' value of 149.06 is 9.7% below this industry median. Based on the distribution chart, Everest Organics ranks #308 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Everest Organics has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Everest Organics' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Everest Organics ranks #308 out of 922 companies for Days Inventory. This puts Everest Organics in the upper half of its industry. The industry median Days Inventory is 165.01. Everest Organics' value of 149.06 is 9.7% below this benchmark. Historically, Everest Organics' own Days Inventory has ranged from 48.17 to 164.85 over the past decade. While the company's 10-year median is 81.95 vs. the industry median of 165.01, Everest Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.01, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Everest Organics's current Days Inventory of 149.06 is 9.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Everest Organics and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Everest Organics's current Days Inventory is 149.06, which is 82% above median its own 10-year median of 81.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Everest Organics stock overvalued right now?
Based on GuruFocus' analysis, Everest Organics (BOM:524790) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹129.33, compared to a current price of ₹307.15 — trading 137.5% above its estimated fair value. The current Days Inventory is 149.06, which is 82% above median its 10-year median of 81.95 and 9.7% below the Drug Manufacturers industry median of 165.01. Everest Organics' overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Everest Organics (BOM:524790), the current Days Inventory is 149.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Everest Organics (BOM:524790) Overvalued in 2026?
Based on GuruFocus' analysis, Everest Organics stock appears to be overvalued.
The current stock price of ₹307.15 is trading 137.5% above its estimated GF Value™ of ₹129.33.
GuruFocus considers Everest Organics to be Significantly Overvalued.
Key valuation signals for BOM:524790:
Days Inventory: 149.06 (82% above median its 10-year median of 81.95)
GF Value™: ₹129.33 vs. price of ₹307.15 (137.5% above fair value)
Industry Position: 9.7% below the Drug Manufacturers median (#308 of 922)
No single metric tells the full story. See the BOM:524790 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Everest Organics Ltd is a pharmaceutical company. It is focused on manufacturing active pharmaceutical ingredients and intermediaries. The products offered by the company include Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, and others. The company operates in one primary business segment namely Active Pharmaceutical Ingredients (API) and their intermediaries. Geographically, it derives a majority of its revenue from India.
47GF Score
Get the complete analysis for BOM:524790
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524790 has been successfully added to your 
